While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Most Oncologic Drugs Advisory Committee members took issue with the lack of dosing optimization and the lack of US patient ...

Co-authors reported grants from Takeda Pharmaceuticals and UCB, consulting for GlaxoSmithKline, and personal fees from the ...

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March ...

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

Sydnie Mason laughs with her lab partner at the SNC GlaxoSmithKline Summer Immersion Experience in Biotech, a biotechnology ...

GSK announced today that Health Canada has approved Blenrep (belantamab mafodotin for injection) in combination with ...

A two-week program at North Carolina Central University gives attendees a $1,000 stipend, field trips to local businesses, ...

In addition to UBS, GlaxoSmithKline also received a Hold from TR | OpenAI – 4o’s Veda Pharmyne in a report issued today. However, on July 15, Bank of America Securities maintained a Sell rating on ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline, with a price target of £14.50. The company’s shares closed yesterday at p1,402.50. Take advantage of ...

JP Morgan reported in their recent outlook piece that "The backdrop for the European consumer is also improving. Real wages ...

The analyst further reasoned that the high ocular toxicity rates, including keratopathy and visual acuity changes, are ...